We are live on ! Find out more
EVH icon

Evolent Health
EVH

69 hedge funds and large institutions have $252M invested in Evolent Health in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

13% more funds holding

Funds holding: 61 → 69 (+8)

0.98% more ownership

Funds ownership: 37.09% → 38.06% (+0.98%)

13% less capital invested

Capital invested by funds: $288M → $252M (-$36.4M)

Holders
69
Holders Change
+8
Holders Change %
+13.11%
% of All Funds
1.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
22
Reduced
15
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$12.3M
2
TCM
TimesSquare Capital Management
New York
+$12.1M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$9.93M
4
BFA
BlackRock Fund Advisors
California
+$6.13M
5
BIT
BlackRock Institutional Trust
California
+$3.93M

Top Sellers

Rank Fund Capital Flow
1
CC
Carlson Capital
Texas
-$8.79M
2
BA
BlackRock Advisors
Delaware
-$8.22M
3
Capital Research Global Investors
Capital Research Global Investors
California
-$6.83M
4
HCMT
Highland Capital Management (Texas)
Texas
-$6.05M
5
JHIU
Janus Henderson Investors US
Colorado
-$4.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$1.71M +$2.09M +107,200 New
PAM
27
Panagora Asset Management
Massachusetts
$1.51M +$1.84M +94,354 New
Massachusetts Financial Services
28
Massachusetts Financial Services
Massachusetts
$1.46M – – –
Deutsche Bank
29
Deutsche Bank
Germany
$1.45M +$526K +26,951 +42%
GPCM
30
Granite Point Capital Management
Massachusetts
$1.4M -$101K -5,158 -6%
BG
31
BlackRock Group
United Kingdom
$1.16M -$2.65M -135,775 -65%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$857K +$563K +28,837 +116%
Geode Capital Management
33
Geode Capital Management
Massachusetts
$804K +$983K +50,405 New
Loomis, Sayles & Company
34
Loomis, Sayles & Company
Massachusetts
$786K +$335K +17,192 +54%
USAA
35
United Services Automobile Association
Texas
$766K +$11.7K +600 +1%
BIM
36
BlackRock Investment Management
Delaware
$702K +$33K +1,694 +4%
Norges Bank
37
Norges Bank
Norway
$638K – – –
TCIM
38
TIAA CREF Investment Management
New York
$627K +$766K +39,273 New
CS
39
Credit Suisse
Switzerland
$621K +$759K +38,887 New
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$619K +$756K +38,757 New
Bank of Montreal
41
Bank of Montreal
Ontario, Canada
$594K +$531K +27,200 +272%
Renaissance Technologies
42
Renaissance Technologies
New York
$567K +$693K +35,500 New
BCCM
43
Blue Clay Capital Management
Minnesota
$501K – – –
DY
44
Dowling & Yahnke
California
$479K – – –
Northern Trust
45
Northern Trust
Illinois
$434K +$531K +27,206 New
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$385K +$470K +24,100 New
TRCT
47
Tower Research Capital (TRC)
New York
$334K +$388K +19,902 +1,990%
Morgan Stanley
48
Morgan Stanley
New York
$323K -$842K -43,147 -68%
GPGA
49
Grandeur Peak Global Advisors
Utah
$321K – – –
Tudor Investment Corp
50
Tudor Investment Corp
Connecticut
$243K -$625K -32,019 -68%
1
2
3 4

EVH Hedge Fund Activity: Q3 2015 in Review

69 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q3 2015, worth a combined $252M — down 13% from $288M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new EVH positions and 15 closed out — a net gain of 8 holders — while 22 added to existing stakes and 15 trimmed.

The largest buyer was Vanguard Group, adding an estimated $12.3M. The largest seller was Carlson Capital, exiting entirely with an estimated $8.79M sold.

  • 69 institutional investors held Evolent Health (EVH) as of Q3 2015, up from 61 in Q2 2015.
  • Funds reported $252M of Evolent Health stock for Q3 2015, down 13% quarter-over-quarter.
  • 23 funds opened new Evolent Health positions in Q3 2015 and 15 closed out, a net change of +8 holders.
  • The largest Evolent Health buyer in Q3 2015 was Vanguard Group, an estimated $12.3M added.
  • The largest Evolent Health seller in Q3 2015 was Carlson Capital, an estimated $8.79M sold.

Based on aggregated 13F filings for Q3 2015.